Alexis ARZIMANOGLOU (Lyon, France)
Myriam CARECCHIO (Padova, Italy)
Diane DOUMMAR (Paris, France)
Renzo GUERRINI (Firenze, Italy)
Philippe KAHANE (Grenoble, France)
Michael KRUER (Phoenix, USA)
Manju KURIAN (London, UK)
Vincenzo LEUZZI (Roma, Italy)
Jean-Pierre LIN (London, UK)
Jonathan MINK (Rochester, USA)
Nardo NARDOCCI (Milano, Italy)
Ingrid SCHEFFER (Melbourne, Australia)


Thursday, February 6th, 2020

Session 1: Background

10h00 – 10h30: Co-occurrence of movement disorders and epilepsy: an historical overview - Renzo Guerrini (Firenze, Italy)

10h30 – 11h00: The hunting of causative genes - Manju Kurian (London, UK)

11h00 – 11h30: Discussion

11h30 –12h00: Coffee Break


Session 2: Background

12h00 – 12h30: Basic cellular mechanisms involved in movement disorders and epilepsy J. Mink (Rochester, USA)

12h30 – 13h: Pathways involved in the co-occurrence of movement disorders and epilepsyP. Kahane (Grenoble, France)

13h – 13h30: Discussion

13h30 – 14h30: Lunch & Posters

14h30 – 15h30: Video session-1


Session 3: Clinical spectrum

15h30 – 16h00: Disorders with fluctuations and/or paroxysmal dyskinesia- ADY5 and ATP1A3 related diseases

16h00 – 16h30: Complex hyperkinetic movement disorders as a core feature of GSMDE. ADCY5, GNAO1 and PDE10A related diseases - M. Carecchio (Padova, Italy)

16h30 – 17h00: Discussion

17h00 – 17h30: Coffee Break


Session 4: Clinical spectrum

17h30 – 18h00: GSMDE with myoclonic epilepsy as main sign. TBC1D24 related diseasesR. Guerrini (Firenze, Italy) & P. Verstreken

18h00 – 18h45: Movement disorders associated with different genetic, developmental and epileptic encephalopathies. FOXG1 and STBT1 related diseases – I. Scheffer (Melbourne, Australia)

18h45 – 19h15: GSMDE due to loss- of-function mutations. FRRS1L and other genetic related diseases - Michael Kruer (Phoenix, USA)

19h15 – 19h45: Discussion

19h45 – 20h45: Video session-2


Friday, February 7th, 2020

Session 5

8h45 – 9h15: When the movement disorder is the dominant feature in GSMDED. Doummar (Paris, France)

11h15 – 11h45: When epilepsy is the dominant feature in GSMDE

11h45 – 12h15: Discussion

12h15 – 12h45: Coffee Break


Session 6: Clinical spectrum

12h45 – 13h15: When neurodevelopmental deficit is in the frontline in GSMDEV. Leuzzi (Rome, Italy)

13h15 – 13h45: GSMDE with parkinsonism as main sign

13h45 – 14h15: Lunch & Posters

15h15 – 16h15: Video session-3


Session 7: Therapeutics

16h15 – 16h45: Medical treatment of the epilepsy in GSMDE A. Arzimanoglou (Lyon, France)

16h45 – 17h15: Medical Treatment of the movement disorder - Giovanna Zorzi (Milano, Italy)

17h15 – 17h45: The place of deep brain stimulation in GSMDEJ-P Lin (London, UK)

17h45 – 18h15: Innovative treatment perspectives

18h15 – 18h45: Discussion

18h45 – 19h45: Video session-4



Copyright © key4events - All rights reserved